Variant report
Variant | esv3346648 |
---|---|
Chromosome Location | chr7:147528544-147531017 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:20)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:20 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr7:147528563-147528613 | K562 | blood: | n/a | n/a |
2 | CTCF | chr7:147528579-147528619 | MCF-7 | breast: | n/a | n/a |
3 | CTCF | chr7:147528544-147528640 | LNCaP | prostate: | n/a | n/a |
4 | CTCF | chr7:147528525-147528627 | LNCaP | prostate: | n/a | n/a |
5 | GTF2F1 | chr7:147530867-147530885 | H1-hESC | embryonic stem cell: | n/a | n/a |
6 | HCFC1 | chr7:147530829-147530978 | K562 | blood: | n/a | n/a |
7 | JUND | chr7:147530632-147531008 | H1-hESC | embryonic stem cell: | n/a | n/a |
8 | MAX | chr7:147528510-147528665 | NB4 | blood: | n/a | chr7:147528631-147528641 |
9 | POLR2A | chr7:147531008-147531113 | GM12878 | blood: | n/a | n/a |
10 | POLR2A | chr7:147528853-147528979 | ProgFib | skin: | n/a | n/a |
11 | RFX5 | chr7:147530087-147530088 | K562 | blood: | n/a | n/a |
12 | SIX5 | chr7:147530720-147531103 | H1-hESC | embryonic stem cell: | n/a | n/a |
13 | SIX5 | chr7:147530655-147531073 | H1-hESC | embryonic stem cell: | n/a | n/a |
14 | YY1 | chr7:147530428-147531048 | H1-hESC | embryonic stem cell: | n/a | n/a |
15 | YY1 | chr7:147530464-147531013 | H1-hESC | embryonic stem cell: | n/a | n/a |
16 | ZNF143 | chr7:147530784-147531057 | K562 | blood: | n/a | n/a |
17 | ZNF143 | chr7:147530750-147531050 | GM12878 | blood: | n/a | n/a |
18 | ZNF143 | chr7:147530344-147531113 | H1-hESC | embryonic stem cell: | n/a | n/a |
19 | ZNF143 | chr7:147530749-147531038 | Hela-S3 | cervix: | n/a | n/a |
20 | ZNF274 | chr7:147529213-147530213 | K562 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNU6-1184P | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12532085 | chr7:147528589-147528590 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs527732068 | chr7:147528607-147528608 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs12540078 | chr7:147528625-147528626 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs369143073 | chr7:147528626-147528627 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs371050663 | chr7:147528853-147528854 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs528663875 | chr7:147530411-147530412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs12531111 | chr7:147530449-147530450 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs570451333 | chr7:147530497-147530498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187202934 | chr7:147530498-147530499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs549812416 | chr7:147530520-147530521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs375943377 | chr7:147530526-147530527 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs569642586 | chr7:147530565-147530566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs539460879 | chr7:147530595-147530596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs551319478 | chr7:147530599-147530600 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs535775862 | chr7:147530615-147530616 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs76877797 | chr7:147530622-147530623 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs77792317 | chr7:147530660-147530661 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs555731218 | chr7:147530678-147530679 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs191662495 | chr7:147530681-147530682 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs183870417 | chr7:147530719-147530720 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs557884963 | chr7:147530732-147530733 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs146250091 | chr7:147530767-147530768 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs543474891 | chr7:147530784-147530785 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs556960385 | chr7:147530801-147530802 | Flanking Active TSS Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs139256717 | chr7:147530822-147530823 | Flanking Active TSS Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs12531773 | chr7:147530842-147530843 | Flanking Active TSS Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs188391049 | chr7:147530863-147530864 | Flanking Active TSS Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs538181797 | chr7:147530940-147530941 | Flanking Active TSS Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs559787816 | chr7:147530976-147530977 | Flanking Active TSS Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs142862604 | chr7:147530978-147530979 | Flanking Active TSS Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17133270 | CNVD |
Schizophrenia | 17646849 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Gastric cancer | 16891809 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Cancer | 20164920 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Autism | 20808228 | CNVD |
Schizophrenia | 20838587 | CNVD |
Schizophrenia | 20718829 | CNVD |
Neuropsychiatric disorder | 21827697 | CNVD |
Melanoma | 20877625 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 20964600 | CNVD |
Epilepsy | 17646849 | CNVD |
Mental retardation | 19896112 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Heart disease | 21282601 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Lobular carcinoma | 20920651 | CNVD |
Long-qt syndrome | 20920651 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:147530400-147530600 | Enhancers | Brain Anterior Caudate | brain |
2 | chr7:147530400-147530600 | Enhancers | Brain Substantia Nigra | brain |
3 | chr7:147530400-147530800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr7:147530400-147530800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr7:147530400-147530800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr7:147530400-147530800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr7:147530400-147531200 | Enhancers | Brain Inferior Temporal Lobe | brain |
8 | chr7:147530400-147531800 | Enhancers | Brain Angular Gyrus | brain |
9 | chr7:147530600-147530800 | Flanking Active TSS | Brain Anterior Caudate | brain |
10 | chr7:147530600-147530800 | Flanking Active TSS | Brain Substantia Nigra | brain |
11 | chr7:147530600-147531000 | Enhancers | Brain Hippocampus Middle | brain |
12 | chr7:147530600-147531200 | Enhancers | Brain Dorsolateral Prefrontal Cortex | brain |
13 | chr7:147530600-147531600 | Enhancers | Brain Cingulate Gyrus | brain |
14 | chr7:147530800-147531000 | Active TSS | Brain Substantia Nigra | brain |
15 | chr7:147530800-147531200 | Flanking Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
16 | chr7:147530800-147531400 | Active TSS | Brain Anterior Caudate | brain |
17 | chr7:147531000-147531200 | Flanking Active TSS | Brain Hippocampus Middle | brain |
18 | chr7:147531000-147531400 | Enhancers | Fetal Brain Female | brain |